Global fluoroscopy systems market will reach $ 8,886.7 million by 2032, growing by 5.0% annually over 2022-2032, driven by the increasing prevalence in incidence of cardiovascular diseases and other disorders, the rising awareness for fluoroscopic equipment, superior visualization properties of fluoroscopic imaging, and growing geriatric population, and the technological advancement due to the increasing R&D investment.
Highlighted with 81 tables and 76 figures, this 151-page report "Global Fluoroscopy Systems Market 2022-2032 by Product (Devices, Fixed C-arms, Mobile C-arms), Application, End User (Hospitals, Diagnostic Centers, Specialty Clinics), and Region: Trend Forecast and Growth Opportunity" is based on comprehensive research of the entire global fluoroscopy systems market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global fluoroscopy systems market in every aspect of the classification from perspectives of Product, Application, End User, and Region.
Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Fluoroscopy Devices
• Fixed C-arms
• Mobile C-arms
o Full-size C-arms
o Mini C-arms
Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• General Surgery
• Pain Management and Trauma
• Other Applications
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Diagnostic Centers
• Specialty Clinics
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE，Saudi Arabia， South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and split of each national market by Product, Application and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Adani Systems Inc.
ATON GmbH (Ziehm Imaging Inc. and OrthoScan Inc.)
Canon Medical Systems Corporation
Carestream Health (Onex Corporation)
FUJIFILM Holdings Corporation
General Electric Company (GE Healthcare)
Koninklijke Philips NV
Siemens Healthcare GmbH
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)